loading page

High levels of circulating IL-6 and IL-8 signature predicts COVID-19 severity
  • +3
  • Didem OZGUR,
  • MURAT KARAMESE,
  • ALPAY MEDET ALIBEYOGLU,
  • ONUR ALKAN,
  • Naci SENKAL,
  • Emin Ediz TUTUNCU
Didem OZGUR

Corresponding Author:[email protected]

Author Profile
MURAT KARAMESE
Kafkas University
Author Profile
ALPAY MEDET ALIBEYOGLU
Istanbul University
Author Profile
ONUR ALKAN
Istanbul University
Author Profile
Naci SENKAL
Istanbul University
Author Profile
Emin Ediz TUTUNCU
Kafkas University
Author Profile

Abstract

Background Severe acute respiratory syndrome corona virus 2 (SARS-CoV- 2) infection may trigger a cytokine storm which is characterized by uncontrolled overproduction of proinflammatory cytokines. We aimed to determine associations of circulating levels of inflammatory cytokines with severity of COVID-19. Materials and methods This is a cross-sectional study including 46 severe and 32 mildly symptomatic coronavirus disease 2019 (COVID-19) patients. The serum levels of cytokines, chemokines, and growth factors were determined by using a Bio-Plex Pro™ Human Cytokine Screening Panel (Bio-Rad, Hercules, CA, USA). Results A total of 78 patients with confirmed COVID-19, 54 males and 24 females were included in this study. The mean age was 43.1±13.3 and 58.2±15 in mild and severe patients, respectively. Severe patients were characterized by significant laboratory abnormalities such as increased WBC (p=0.002) and neutrophil counts (p=0.001), higher levels of ALT (p=0.030), AST (p=0.002), LDH (p<0.001), ure (p=0.013), ferritin (p<0.001), D-dimer (p=0.042), CRP (p<0.001) and decreased lymphocyte (p<0.001) and platelet (p=0.045) counts. The levels of IL-6, IL-8, IL-13, TNF-α, IFN-γ, MIP-1β and MCP-1 were increased in the severe group compared to the mild group but only significant differences were observed for IL-6 (p<0.001) and IL-8 (p<0.001) levels. Conclusions Serum IL-6 and IL-8 levels can be used as potential prognostic biomarkers of disease severity in COVID-19 patients.